OracleBio will be attending the European Society for Medical Oncology – ESMO Congress 2019, which takes place from the 27th of September to 1st of October 2019 in Barcelona, Spain.
OracleBio offers a range of digital pathology services to support pre-clinical and clinical oncology R&D. Using immunohistochemistry and immunoflourescence techniques, we are able to produce a variety of quantifiable results valuable to oncology research, such as immune cell number, immune cell co-localisation and spatial distribution within the tumor microenvironment. Click here to find out more information about how our services can support your oncology research.
The European Society for Medical Oncology – ESMO Congress 2019 will bring together researchers, clinicians, pharmaceutical industry professionals, patient advocates, and journalists to shed the light on the latest advancements in oncology treatments and the translation of science into better patient care. To find out more, please click here.
Lorcan Sherry, OracleBio’s Chief Scientific Officer will be in attendance throughout the meeting. If you would like to learn more about OracleBio’s services please contact us.
To keep up to date with all OracleBio news and events, follow us on LinkedIn by clicking the button below: